Micro-X Ltd (MX1) - Net Assets
Based on the latest financial reports, Micro-X Ltd (MX1) has net assets worth AU$5.59 Million AUD (≈ $3.96 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$17.41 Million ≈ $12.32 Million USD) and total liabilities (AU$11.82 Million ≈ $8.36 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of Micro-X Ltd to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$5.59 Million |
| % of Total Assets | 32.12% |
| Annual Growth Rate | N/A |
| 5-Year Change | -77.9% |
| 10-Year Change | -58.59% |
| Growth Volatility | 63.07 |
Micro-X Ltd - Net Assets Trend (2014–2025)
This chart illustrates how Micro-X Ltd's net assets have evolved over time, based on quarterly financial data. Also explore MX1 asset base for the complete picture of this company's asset base.
Annual Net Assets for Micro-X Ltd (2014–2025)
The table below shows the annual net assets of Micro-X Ltd from 2014 to 2025. For live valuation and market cap data, see market cap of Micro-X Ltd.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$7.55 Million ≈ $5.34 Million |
-47.07% |
| 2024-06-30 | AU$14.26 Million ≈ $10.09 Million |
-16.74% |
| 2023-06-30 | AU$17.13 Million ≈ $12.12 Million |
-10.90% |
| 2022-06-30 | AU$19.22 Million ≈ $13.60 Million |
-43.70% |
| 2021-06-30 | AU$34.15 Million ≈ $24.16 Million |
+131.72% |
| 2020-06-30 | AU$14.74 Million ≈ $10.43 Million |
+594.86% |
| 2019-06-30 | AU$-2.98 Million ≈ $-2.11 Million |
-309.63% |
| 2018-06-30 | AU$-727.00K ≈ $-514.40K |
-104.74% |
| 2017-06-30 | AU$15.32 Million ≈ $10.84 Million |
-15.93% |
| 2016-06-30 | AU$18.23 Million ≈ $12.90 Million |
-35.87% |
| 2015-06-30 | AU$28.43 Million ≈ $20.11 Million |
+7630.50% |
| 2014-06-30 | AU$-377.47K ≈ $-267.08K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Micro-X Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 13509123200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$138.35 Million | 1832.94% |
| Other Comprehensive Income | AU$4.60 Million | 60.98% |
| Other Components | AU$65.00K | 0.86% |
| Total Equity | AU$7.55 Million | 100.00% |
Micro-X Ltd Competitors by Market Cap
The table below lists competitors of Micro-X Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Eildon Capital Group
AU:EDC
|
$26.72 Million |
|
Impact Coatings publ AB
ST:IMPC
|
$26.72 Million |
|
Polygiene AB
ST:POLYG
|
$26.73 Million |
|
FatPipe, Inc. Common Stock
NASDAQ:FATN
|
$26.73 Million |
|
CPI Aerostructures Inc
NYSE:CVU
|
$26.71 Million |
|
Sanatana Resources
V:STA
|
$26.71 Million |
|
Econframe Bhd
KLSE:0227
|
$26.71 Million |
|
DIGITAL WORKFORCE SRV.EO1
F:DQ4
|
$26.70 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Micro-X Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 14,261,000 to 7,548,000, a change of -6,713,000 (-47.1%).
- Net loss of 13,895,000 reduced equity.
- Share repurchases of 355,000 reduced equity.
- New share issuances of 6,365,000 increased equity.
- Other comprehensive income increased equity by 502,000.
- Other factors increased equity by 670,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-13.89 Million | -184.09% |
| Share Repurchases | AU$355.00K | -4.7% |
| Share Issuances | AU$6.37 Million | +84.33% |
| Other Comprehensive Income | AU$502.00K | +6.65% |
| Other Changes | AU$670.00K | +8.88% |
| Total Change | AU$- | -47.07% |
Book Value vs Market Value Analysis
This analysis compares Micro-X Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.20x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-06-30 | AU$-0.02 | AU$0.05 | x |
| 2015-06-30 | AU$0.33 | AU$0.05 | x |
| 2016-06-30 | AU$0.28 | AU$0.05 | x |
| 2017-06-30 | AU$0.12 | AU$0.05 | x |
| 2018-06-30 | AU$-0.01 | AU$0.05 | x |
| 2019-06-30 | AU$-0.02 | AU$0.05 | x |
| 2020-06-30 | AU$0.06 | AU$0.05 | x |
| 2021-06-30 | AU$0.09 | AU$0.05 | x |
| 2022-06-30 | AU$0.04 | AU$0.05 | x |
| 2023-06-30 | AU$0.03 | AU$0.05 | x |
| 2024-06-30 | AU$0.03 | AU$0.05 | x |
| 2025-06-30 | AU$0.01 | AU$0.05 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Micro-X Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -184.09%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -106.45%
- • Asset Turnover: 0.59x
- • Equity Multiplier: 2.93x
- Recent ROE (-184.09%) is below the historical average (-57.89%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | AU$-347.79K |
| 2015 | -35.75% | -14115.28% | 0.00x | 1.09x | AU$-13.01 Million |
| 2016 | -58.93% | -1204.15% | 0.04x | 1.33x | AU$-12.56 Million |
| 2017 | -84.31% | -1960.55% | 0.03x | 1.68x | AU$-14.45 Million |
| 2018 | 0.00% | -1032.67% | 0.11x | 0.00x | AU$-16.52 Million |
| 2019 | 0.00% | -509.27% | 0.20x | 0.00x | AU$-9.54 Million |
| 2020 | -68.31% | -236.81% | 0.13x | 2.29x | AU$-11.54 Million |
| 2021 | -43.14% | -390.64% | 0.08x | 1.31x | AU$-18.15 Million |
| 2022 | -88.89% | -190.51% | 0.29x | 1.63x | AU$-19.01 Million |
| 2023 | -62.79% | -71.67% | 0.50x | 1.77x | AU$-12.47 Million |
| 2024 | -68.47% | -64.15% | 0.57x | 1.89x | AU$-11.19 Million |
| 2025 | -184.09% | -106.45% | 0.59x | 2.93x | AU$-14.65 Million |
Industry Comparison
This section compares Micro-X Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $61,040,828
- Average return on equity (ROE) among peers: -33.85%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Micro-X Ltd (MX1) | AU$5.59 Million | 0.00% | 2.11x | $26.71 Million |
| 4DMEDICAL Ltd (4DX) | $64.24 Million | -46.81% | 0.48x | $1.63 Billion |
| Adherium Ltd (ADR) | $-4.76 Million | 0.00% | 0.00x | $7.37 Million |
| Aroa Biosurgery Ltd (ARX) | $6.92 Million | -23.35% | 0.08x | $150.91 Million |
| Atomo Diagnostics Ltd (AT1) | $-5.47 Million | 0.00% | 0.00x | $13.76 Million |
| Avita Medical Inc (AVH) | $5.12 Million | -224.74% | 0.50x | $132.15 Million |
| Anteris Technologies Global Corp (AVR) | $22.64 Million | -106.07% | 0.18x | $570.83 Million |
| Control Bionics Ltd (CBL) | $5.05 Million | -38.22% | 0.07x | $18.95 Million |
| Cardiex Ltd (CDX) | $4.88 Million | 56.04% | 0.31x | $13.23 Million |
| Compumedics Ltd (CMP) | $8.51 Million | 8.89% | 1.37x | $41.70 Million |
| Cochlear Ltd (COH) | $503.28 Million | 35.79% | 0.47x | $4.60 Billion |
About Micro-X Ltd
Micro-X Limited designs, develops, manufactures, and commercializes imaging products for healthcare, defense, and security markets through cold cathode X-ray technology. The company provides carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components. It also provides Rover Plus for medical performance in a mobile system; Head CT, a standard ambulance or … Read more